Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
暂无分享,去创建一个
Hanna Göransson | Anders Isaksson | Gunnar Juliusson | Richard Rosenquist | Mattias Jansson | Henrik Hjalgrim | A. Isaksson | H. Göransson | G. Juliusson | R. Rosenquist | N. Cahill | H. Hjalgrim | C. Geisler | J. Jurlander | L. Mansouri | J. Lundin | K. Smedby | M. Rasmussen | Anne Mette Buhl | K. Karlsson | Rebeqa Gunnarsson | Jesper Jurlander | Markus Rasmussen | Larry Mansouri | R. Gunnarsson | Karin Karlsson | Nicola Cahill | Jeanette Lundin | Stefan Norin | Karin Ekström Smedby | Christian Geisler | A. Buhl | M. Jansson | S. Norin | Rebeqa Gunnarsson | Hanna Göransson
[1] D. Oscier,et al. Karyotypic evolution in B‐cell chronic lymphocytic leukaemia , 1991, Genes, chromosomes & cancer.
[2] T. Haferlach,et al. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping , 2007, Leukemia.
[3] T. Shanafelt,et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] O. Bernard,et al. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages. , 2010, Leukemia research.
[5] G. Gahrton,et al. Chromosomal aberrations in progressive and indolent chronic B-lymphocytic leukaemia. A longitudinal study. , 1988, Acta oncologica.
[6] M. Kaminski,et al. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. , 2008, Cancer research.
[7] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] L. Zech,et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. , 1985, Blood.
[9] Terence P. Speed,et al. Genome analysis A genotype calling algorithm for affymetrix SNP arrays , 2005 .
[10] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[11] Jens Timmer,et al. Using High-density Snp Arrays Genome-wide Analysis of Dna Copy Number Changes and Loh in Cll , 2022 .
[12] Marie-Paule Lefranc,et al. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..
[13] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[14] Axel Benner,et al. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival , 2007, Haematologica.
[15] P. Nowell,et al. Karyotypic stability in chronic B-cell leukemia. , 1988, Cancer genetics and cytogenetics.
[16] B. Lakshmi,et al. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). , 2009, Blood.
[17] D. Oscier,et al. 13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia. , 2009 .
[18] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Knuutila,et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.
[20] H. Adami,et al. Ultraviolet radiation exposure and risk of malignant lymphomas. , 2005, Journal of the National Cancer Institute.
[21] C. Ottensmeier,et al. Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator. , 2005, Methods in molecular medicine.
[22] T. Haferlach,et al. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype , 2009, Leukemia.
[23] Aileen B. Sedman,et al. A longitudinal study , 1987 .
[24] K. Coombes,et al. Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. , 2009, Leukemia research.
[25] Francesco Bertoni,et al. Genome‐wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion , 2008, British journal of haematology.
[26] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[27] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[28] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[29] C. Croce,et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] Z. Zemanová,et al. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. , 2009, Neoplasma.
[31] L. Peterson,et al. Secondary Abnormalities of Chromosome 6q in B‐Cell Chronic Lymphocytic Leukemia: A Sequential Study of Karyotypic Instability in 51 Patients , 1998, American journal of hematology.
[32] Christian J Stoeckert,et al. STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. , 2006, Genome research.
[33] L. Holmberg,et al. Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data , 2009, PloS one.
[34] A Benner,et al. Genomic aberrations and survival in chronic lymphocytic leukemia. , 2000, The New England journal of medicine.
[35] F. Ferrari,et al. Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion , 2010, Clinical Cancer Research.
[36] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[37] D. de Jong,et al. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. , 2008, The Journal of molecular diagnostics : JMD.
[38] J. Staaf,et al. Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients , 2010, Leukemia.
[39] G. Gahrton,et al. Consistency of chromosomal aberrations in chronic B‐lymphocytic leukemia. A longitudinal cytogenetic study of 41 patients , 1988, Cancer.
[40] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[41] Joshua M. Korn,et al. Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.
[42] S. Ogawa,et al. Molecular allelokaryotyping of early‐stage, untreated chronic lymphocytic leukemia , 2008, Cancer.
[43] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[44] Andrea Califano,et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.